4.4 Article

Overexpression of a disintegrin and metalloprotease 8 in human gliomas is implicated in tumor progression and prognosis

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

ADAM8 substrate specificity: Influence of pH on pre-processing and proteoglycan degradation

Troii Hall et al.

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2009)

Article Pathology

Expression of ADAMs (a disintegrin and metalloprotease) in the human lung

Antoon Dijkstra et al.

VIRCHOWS ARCHIV (2009)

Article Cell Biology

ADAM8 expression is associated with increased invasiveness and reduced patient survival in pancreatic cancer

N. Valkovskaya et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2007)

Review Clinical Neurology

The 2007 WHO classification of tumours of the central nervous system

David N. Louis et al.

ACTA NEUROPATHOLOGICA (2007)

Article Medicine, General & Internal

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

R Stupp et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Review Clinical Neurology

Epidemiology and etiology of gliomas

H Ohgaki et al.

ACTA NEUROPATHOLOGICA (2005)

Article Oncology

ADAM8 as a novel serological and histochemical marker for lung cancer

N Ishikawa et al.

CLINICAL CANCER RESEARCH (2004)

Article Biochemistry & Molecular Biology

The enzymatic activity of ADAM8 and ADAM9 is not regulated by TIMPs

A Amour et al.

FEBS LETTERS (2002)

Article Clinical Neurology

Distinct expression patterns and levels of enzymatic activity of matrix metalloproteinases and their inhibitors in primary brain tumors

A Pagenstecher et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2001)